These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19769624)

  • 1. Effects of octreotide exposure during pregnancy in acromegaly.
    Maffei P; Tamagno G; Nardelli GB; Videau C; Menegazzo C; Milan G; Calcagno A; Martini C; Vettor R; Epelbaum J; Sicolo N
    Clin Endocrinol (Oxf); 2010 May; 72(5):668-77. PubMed ID: 19769624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues--Observations in two patients with acromegaly and severe headache.
    Marina D; Burman P; Klose M; Casar-Borota O; Luque RM; Castaño JP; Feldt-Rasmussen U
    Growth Horm IGF Res; 2015 Oct; 25(5):262-7. PubMed ID: 26188991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients.
    Fatti LM; Scacchi M; Lavezzi E; Pecori Giraldi F; De Martin M; Toja P; Michailidis G; Stramba-Badiale M; Cavagnini F
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):626-30. PubMed ID: 17054464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide.
    Boulanger C; Vezzosi D; Bennet A; Lorenzini F; Fauvel J; Caron P
    J Endocrinol Invest; 2004 May; 27(5):465-70. PubMed ID: 15279081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy.
    Caron P; Buscail L; Beckers A; Estève JP; Igout A; Hennen G; Susini C
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3771-6. PubMed ID: 9360539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
    Laczi F; Magony S; Julesz J
    Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.
    O'Leary DR; Kuhn S; Kniss KL; Hinckley AF; Rasmussen SA; Pape WJ; Kightlinger LK; Beecham BD; Miller TK; Neitzel DF; Michaels SR; Campbell GL; Lanciotti RS; Hayes EB
    Pediatrics; 2006 Mar; 117(3):e537-45. PubMed ID: 16510632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The somatostatin analogue SOM230, compared with octreotide, induces differential effects in several metabolic pathways in acromegalic patients.
    van der Hoek J; van der Lelij AJ; Feelders RA; de Herder WW; Uitterlinden P; Poon KW; Boerlin V; Lewis I; Krahnke T; Hofland LJ; Lamberts SW
    Clin Endocrinol (Oxf); 2005 Aug; 63(2):176-84. PubMed ID: 16060911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic-pharmacodynamic comparison of a novel multiligand somatostatin analog, SOM230, with octreotide in patients with acromegaly.
    Ma P; Wang Y; van der Hoek J; Nedelman J; Schran H; Tran LL; Lamberts SW
    Clin Pharmacol Ther; 2005 Jul; 78(1):69-80. PubMed ID: 16003295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic abnormalities of somatostatin receptors in pituitary tumors.
    Lania A; Mantovani G; Spada A
    Mol Cell Endocrinol; 2008 May; 286(1-2):180-6. PubMed ID: 17913341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison between integrated 24-hour concentrations of growth hormone, insulin-like growth factor I and prolactin in acromegalic patients treated with octreotide and patients treated with octreotide LAR].
    Esposito V; Esposito D; Lo Iudice G
    Minerva Endocrinol; 2001 Dec; 26(4):289-92. PubMed ID: 11782718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone isoforms in acromegalic patients before and after treatment with octreotide LAR.
    Lima GA; Wu Z; Silva CM; Barbosa FR; Dias JS; Schrank Y; Strasburger CJ; Gadelha MR
    Growth Horm IGF Res; 2010 Apr; 20(2):87-92. PubMed ID: 19884028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does partial surgical tumour removal influence the response to octreotide-LAR in acromegalic patients previously resistant to the somatostatin analogue?
    Jallad RS; Musolino NR; Kodaira S; Cescato VA; Bronstein MD
    Clin Endocrinol (Oxf); 2007 Aug; 67(2):310-5. PubMed ID: 17555503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of cerebral palsy during labour: role of foetal lactate.
    Borruto F; Comparetto C; Treisser A
    Arch Gynecol Obstet; 2008 Jul; 278(1):17-22. PubMed ID: 18071726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of 189 acromegalic patients with the somatostatin analog octreotide. Results of the International Multicenter Acromegaly Study Group.
    Vance ML; Harris AG
    Arch Intern Med; 1991 Aug; 151(8):1573-8. PubMed ID: 1872661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Experience in treating acromegalic patients with long-acting octreotide].
    Szücs N; Mészáros J; Czirják S; Mondok A; Varga I; Gláz E
    Orv Hetil; 2002 May; 143(19 Suppl):1066-70. PubMed ID: 12063862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous octreotide test predicts the long term outcome of treatment with octreotide-long-acting repeatable in active acromegaly.
    Biermasz NR; Pereira AM; Smit JW; Romijn JA; Roelfsema F
    Growth Horm IGF Res; 2005 Jun; 15(3):200-6. PubMed ID: 15935982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of maternal asthma on placental and cord blood protein profiles.
    Murphy VE; Johnson RF; Wang YC; Akinsanya K; Gibson PG; Smith R; Clifton VL
    J Soc Gynecol Investig; 2005 Jul; 12(5):349-55. PubMed ID: 15979547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.